Profile
Kieran Murphy is the founder of Cora Therapeutics, Inc. and held the titles of Chairman and President.
Kieran Murphy active positions
Companies | Position | Start |
---|---|---|
Cora Therapeutics, Inc.
Cora Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cora Therapeutics, Inc. is a data-driven health solutions company based in Toronto, CA. The product is clinically proven and patented to minimize the irreversible damage to DNA caused by radiation from medical imaging such as CT and X-ray, and cosmic radiation on planes at high altitudes. The Canadian company, under the leadership of Dr. Kieran Murphy, a renowned interventional neuroradiologist, is committed to minimizing the collateral damage caused by radiation exposure. The team is complemented by the esteemed scientific advisor, Dr. Mark Tarnopolsky, who is a frontrunner in evaluating and developing nutraceutical treatments for disorders associated with oxidative stress. The company's first product, Halo antioxidant, is launching in 2022. The company's formulations are developed using the wealth of knowledge possessed by their team and validated through clinical research. The company was founded by Kieran Murphy, and the CEO is David Simpson. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Cora Therapeutics, Inc.
Cora Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cora Therapeutics, Inc. is a data-driven health solutions company based in Toronto, CA. The product is clinically proven and patented to minimize the irreversible damage to DNA caused by radiation from medical imaging such as CT and X-ray, and cosmic radiation on planes at high altitudes. The Canadian company, under the leadership of Dr. Kieran Murphy, a renowned interventional neuroradiologist, is committed to minimizing the collateral damage caused by radiation exposure. The team is complemented by the esteemed scientific advisor, Dr. Mark Tarnopolsky, who is a frontrunner in evaluating and developing nutraceutical treatments for disorders associated with oxidative stress. The company's first product, Halo antioxidant, is launching in 2022. The company's formulations are developed using the wealth of knowledge possessed by their team and validated through clinical research. The company was founded by Kieran Murphy, and the CEO is David Simpson. | Commercial Services |
- Stock Market
- Insiders
- Kieran Murphy